Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.

85.81 2.05 −2.33%
Market cap
$15.0B
P/E
10.4×
Fwd P/E
39.0×
Dividend yield
—
F-score
5/9
Altman Z
2.22
Beneish M
−2.07
Dividend safety
n/a

Solventum Corporation (SOLV) Book value per share

Alert me on Book value per share

Solventum Corporation's book value per share at the end of fiscal 2025 was 29.0×, up 69.8% from 17.1× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 27.8×. Solventum Corporation ranks 15th of 55 Medical Instruments & Supplies companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 29.0× 69.75%
FY2024 17.1× (74.71%)
FY2023 67.6× —
FY2022 0.0× —

Quarterly newest first

Period Book value per share Change
Jun 2026 27.8× (2.56%)
Mar 2026 28.5× (1.64%)
Dec 2025 29.0× 1.38%
Sep 2025 28.6× 36.63%
11 more quarters

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on SOLV